Phase III comparison of standard doxorubicin and cyclophosphamide versus weekly doxorubicin and daily oral cyclophosphamide plus granulocyte colony-stimulating factor as neoadjuvant therapy for inflammatory and locally advanced breast cancer: SWOG 0
published in: Journal of Clinical Oncology
date of publication: 2011-01-10
language: English
main subject: doxorubicin
Cites articles 16
- 1992-06-01
Date
Title
Article - wd:Q34743442